ADVANCED ENDOMETRIAL CANCER

Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 3 Not yet finished but already full! 1 Completed 1 Terminated 1

Cancer drug cocktail shows promise for uterine tumors, but trial halted early

Disease control Terminated

This study tested a new drug combination for people with advanced endometrial cancer or uterine sarcoma who had not yet received treatment. The combination included an immunotherapy drug (TQB2450) plus chemotherapy, with or without a targeted therapy (anlotinib). The goal was to …

Matched conditions: ADVANCED ENDOMETRIAL CANCER

Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

ADVANCED ENDOMETRIAL CANCER

Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear

Cancer drug cocktail shows promise for uterine tumors, but trial halted early